← FDA Drug Approvals (Drugs@FDA)

CARGLUMIC ACID

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NAVINTA LLC · Approved 2022-06-22

Drug application

FDA Application #

ANDA213395

Application type

Abbreviated New Drug Application (Generic)

Brand name

CARGLUMIC ACID

Generic name

CARGLUMIC ACID

Active ingredients

CARGLUMIC ACID

Dosage form

TABLET, FOR SUSPENSION

Route

ORAL

Marketing status

Prescription

Sponsor

NAVINTA LLC

Manufacturer

Navinta LLC

First approval

2022-06-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown